We found that inhibition of Hsp90 caused tumor growth inhibition and weight loss in xenografted animal models, and correspondingly, FASN levels and lipid accumulation of HCC cells were downregulated in vivo and in vitro. Here, FASN is linked to hepatocellular carcinoma.